NewsAvenda Health’s Unfold AI™ Shown to More Precisely Predict Extraprostatic Extension Risk in Prostate Cancer Patients, Surpassing Conventional MethodologyApril 27, 2023
NewsAvenda Health Announces First Commercial Use of Unfold AI on Prostate Cancer Patients in the U.S.April 25, 2023
NewsProstate Cancer Technology Startup, Avenda Health, Partnering with BioscienceLA to Establish New Life Sciences Innovation Hub in U.S.April 19, 2023
NewsFirst AI-Powered Precision Oncology Platform for Prostate Cancer Care, iQuest Receives FDA ClearanceDecember 13, 2022
NewsCould an Emerging AI Platform Supplant Traditional MRI for Assessing Prostate Cancer?December 7, 2022
News, RecognitionAvenda Health Adds Tech Luminary to Board of Directors and Expands Leadership TeamAugust 26, 2022